Upcoming COCA Call February 16, 2017—2016-2017 Influenza Season Activity and Recommendations for Clinicians

Overview:

Influenza activity in the United States began to increase in early December, remained elevated through mid-January, and is expected to continue for several more weeks. Influenza A(H3N2) viruses have been most common this season, and influenza A(H3N2)-predominant seasons are often associated with more severe illness, particularly among young children and people 65 years and older.

Annual influenza vaccination is recommended for all persons aged 6 months and older, and is the best way to prevent influenza. Available evidence consistently indicates that antiviral treatment, when initiated as early as possible, can be a useful second line of defense to treat influenza illness when indicated and can reduce severe outcomes of influenza.

During this COCA Call, clinicians will learn about 2016–2017 influenza activity to date, and hear an overview of CDC’s recommendations for healthcare providers including influenza vaccination and the use of antiviral medications for the treatment of influenza.

Date: Thursday, February 16, 2017

Time:  2:00–3:00 pm (Eastern Time)

Join by Phone:

888-469-3010 (U.S. Callers)
1-773-756-4803 (International Callers)

Passcode: 3607519

Join by Webinar

The recordings (audio, slides, and transcript) for this call will be posted on the webpage a few days after the COCA Call.

Follow these steps to earn free continuing education.

Objectives:

  • Describe the current status of influenza activity in the United States.
  • Explain the circulating influenza strains seen this season and the implications for clinicians.
  • Discuss antiviral treatment of influenza and implications for patient evaluation, testing, and treatment.

Presenters:

Angela Campbell, MD, MPH
Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Alicia P. Budd, MPH
Epidemiologist
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Accreditation Statements:

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614. 

CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-17-102-L04-P and enduring 0387-0000-17-102-H04-P course category.

Course Category: This activity has been designated as knowledge-based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org.

There is no cost for this program.

DISCLOSURE:CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. This presentation will include discussion of the unlabeled use of a product or products under investigational use.

CDC does not accept commercial support.

Recent Stories
AAOHN Foundation Announces 2018 Medique Research Grant

Official Journal of AAOHN Inducted Into Inaugural Nursing Journal Hall of Fame

AAOHN Member Barbara J. Burgel appointed to the California Occupational Health & Safety Standards Board